Qube Research & Technologies Ltd - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 14 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q2 2024$70
-12.5%
460.0%0.00%
Q1 2024$80
+48.1%
460.0%0.00%
Q4 2023$54
+50.0%
460.0%0.00%
Q3 2023$36460.00%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q2 2024
NameSharesValueWeighting ↓
RA Capital Management 6,991,003$7,899,8330.15%
Kynam Capital Management, LP 535,005$602,6400.08%
Ikarian Capital, LLC 219,501$243,6450.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 603,900$670,3290.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 650,000$734,5000.00%
BOOTHBAY FUND MANAGEMENT, LLC 26,867$30,3600.00%
MORGAN STANLEY 1$10.00%
Renaissance Technologies 95,500$1080.00%
ROYAL BANK OF CANADA 35$00.00%
FMR LLC 24$260.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders